| Item Type | Name |
|
Academic Article
|
The feasibility of inpatient geriatric assessment for older adults receiving induction chemotherapy for acute myelogenous leukemia.
|
|
Academic Article
|
Esthesioneuroblastoma.
|
|
Academic Article
|
Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?
|
|
Academic Article
|
Adjuvant chemotherapy among medicaid-enrolled patients diagnosed with nonmetastatic colon cancer.
|
|
Academic Article
|
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study.
|
|
Academic Article
|
A clinical trial of supervised exercise for adult inpatients with acute myeloid leukemia (AML) undergoing induction chemotherapy.
|
|
Academic Article
|
Toxicity of bevacizumab in combination with chemotherapy in older patients.
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Chemotherapy, Adjuvant
|
|
Concept
|
Drug Therapy, Combination
|
|
Academic Article
|
Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia.
|
|
Academic Article
|
Individualizing treatment decisions for older adults with hematologic malignancies.
|
|
Academic Article
|
CA125 level association with chemotherapy toxicity and functional status in older women with ovarian cancer.
|
|
Academic Article
|
Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML).
|
|
Academic Article
|
Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: effect on chemotherapy-related toxicity and hospitalization during treatment.
|
|
Academic Article
|
Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance).
|
|
Academic Article
|
The prognostic importance of polypharmacy in older adults treated for acute myelogenous leukemia (AML).
|
|
Academic Article
|
Geriatric perspective: how to assess fitness for chemotherapy in acute myeloid leukemia.
|
|
Academic Article
|
Predictors of chemotherapy dose reduction at first cycle in patients age 65 years and older with solid tumors.
|
|
Academic Article
|
High dose cytarabine, mitoxantrone and l-asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly.
|
|
Academic Article
|
Comorbidity, age, and mortality among adults treated intensively for acute myeloid leukemia (AML).
|
|
Academic Article
|
Is distance to chemotherapy an obstacle to adjuvant care among the N.C. Medicaid-enrolled colon cancer patients?
|
|
Academic Article
|
Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer.
|
|
Academic Article
|
Effect of Intensive Chemotherapy on Physical, Cognitive, and Emotional Health of Older Adults with Acute Myeloid Leukemia.
|
|
Academic Article
|
Association between renal function and chemotherapy-related toxicity in older adults with cancer.
|
|
Academic Article
|
Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).
|
|
Academic Article
|
Frailty as determined by a comprehensive geriatric assessment-derived deficit-accumulation index in older patients with cancer who receive chemotherapy.
|
|
Grant
|
Minimizing Physical Function Decline in Older Adults Receiving Chemotherapy
|
|
Academic Article
|
Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial.
|
|
Academic Article
|
Predicting chemotherapy toxicity in older adults and the importance of geriatric assessment.
|
|
Academic Article
|
Outcomes and changes in code status of patients with acute myeloid leukemia undergoing induction chemotherapy who were transferred to the intensive care unit.
|
|
Academic Article
|
A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3-mutated acute myeloid leukemia: CALGB 11001.
|
|
Academic Article
|
Left Ventricular Mass Change After Anthracycline Chemotherapy.
|
|
Academic Article
|
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology.
|
|
Academic Article
|
Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age.
|
|
Academic Article
|
The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance).
|
|
Academic Article
|
Advancements in the management of medically less-fit and older adults with newly diagnosed acute myeloid leukemia.
|
|
Academic Article
|
National Institute on Aging /Alzheimer's Association criteria for Mild Cognitive Impairment applied to chemotherapy treated breast cancer survivors.
|
|
Academic Article
|
Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer.
|